Clarivate (CLVT) Stifel 2024 Cross Sector Insight Conference summary

Strategic growth outlook and investments

• Targeting organic growth acceleration to 4%-6% over the next few years, driven by investments in each business segment.

• Major focus on AI and generative AI integration across products to enhance customer value and drive segment growth.

• Continued investment in flagship products like Web of Science and new AI features such as Researcher Assistant, with launches planned later this year.

• IP segment growth expected from new applications built on Derwent Innovation data, with all modules in market this year.

• Life sciences segment to launch new real-world data analytics solutions, aiming for mid-single-digit growth in coming years.

Revenue model, seasonality, and market dynamics

• Revenue split: 60% subscription, 20% recurring (mainly IP renewals), 20% transactional, with subscription growth stable at 2%.

• Transactional business shows seasonality, with Q2 and Q4 being stronger for academic/government and life sciences, respectively.

• Full-year organic growth expected at 1%, with non-subscription business declining slightly but recurring and transactional segments recovering in H2.

• Academic/government and IP markets viewed as capable of 3%-4% growth, with focus on digital content and analytical tools.

• Competitive dynamics in IP intelligence addressed by modernizing user interfaces and leveraging proprietary data.

AI strategy and competitive positioning

• AI used internally for efficiency and externally to enhance product features, such as generative AI in research and trademark tools.

• Proprietary data and metadata seen as key differentiators against AI-driven competitors, especially in critical use cases.

• New AI-powered visual recognition tools launched in trademark business, leveraging historical data for better accuracy.